back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2023-05-23 12:49 Tx date 2023-05-19 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Miller, Steven Daniel
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$249,994
+29,205 vol $8.56 each |
88,673 | |
| Filed 2023-01-04 17:01 Tx date 2022-12-30 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Miller, Steven Daniel
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$28,818
+4,589 vol $6.28 each |
59,468 | |
| Filed 2022-10-04 16:34 Tx date 2022-09-30 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Miller, Steven Daniel
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$30,619
+4,444 vol $6.89 each |
54,879 | |
| Filed 2022-07-06 15:00 Tx date 2022-06-30 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Miller, Steven Daniel
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$30,622
+3,663 vol $8.36 each |
50,435 | |
| Filed 2022-06-29 12:58 Tx date 2022-06-24 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Miller, Steven Daniel
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+34,387 vol |
46,772 | |
| Filed 2022-04-05 11:59 Tx date 2022-03-31 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Miller, Steven Daniel
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$30,619
+1,340 vol $22.85 each |
12,385 | |
| Filed 2022-01-04 12:53 Tx date 2021-12-31 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Miller, Steven Daniel
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+1,109 vol |
11,045 | |
| Filed 2021-11-30 16:36 Tx date 2021-11-30 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Miller, Steven Daniel
4 - Director of Issuer
Holder: Individual Retirement Account (IRA) (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$241,698
+10,000 vol $24.17 each |
10,000 | |
| Filed 2021-11-30 16:36 Tx date 2021-03-17 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Miller, Steven Daniel
4 - Director of Issuer
Holder: Individual Retirement Account (IRA) (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-11-30 16:33 Tx date 2021-11-30 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Miller, Steven Daniel
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,211,825
+50,000 vol $24.24 each |
50,844 | |
| Filed 2021-11-30 16:31 Tx date 2021-11-30 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Miller, Steven Daniel
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,211,825
+50,000 vol $24.24 each |
||
| Filed 2021-10-04 18:20 Tx date 2021-09-30 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Miller, Steven Daniel
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$30,607
+1,099 vol $27.85 each |
9,936 | |
| Filed 2021-07-05 11:22 Tx date 2021-06-30 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Miller, Steven Daniel
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$30,610
+1,044 vol $29.32 each |
8,837 | |
| Filed 2021-05-03 19:47 Tx date 2021-04-30 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Miller, Steven Daniel
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$249,991
+7,645 vol $32.70 each |
7,793 | |
| Filed 2021-04-30 17:47 Tx date 2021-04-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Miller, Steven Daniel
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$23,250
+744 vol $31.25 each |
844 | |
| Filed 2021-04-30 17:46 Tx date 2021-04-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Miller, Steven Daniel
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-744 vol |
148 | |
| Filed 2021-04-05 13:06 Tx date 2021-03-31 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Miller, Steven Daniel
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$4,697
+148 vol $31.74 each |
892 | |
| Filed 2021-03-24 18:02 Tx date 2021-03-22 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Miller, Steven Daniel
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$24,552
+744 vol $33.00 each |
744 | |
| Filed 2021-03-24 18:01 Tx date 2021-03-17 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Miller, Steven Daniel
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-03-24 18:00 Tx date 2021-03-17 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Miller, Steven Daniel
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
100 |